Agereh Expands Intelligent Transportation Portfolio with Launch of Smart Door Sensor and Retains Hillside C&M Inc.

The Cell and Gene Therapy industry is rapidly advancing, with key players like Novartis, Gilead, and Bristol Myers Squibb leading the market through innovative treatments. Zolgensma gene therapy achieved $1.2B in sales, while Yescarta CAR-T therapy reached $1.498B in global sales. The FDA has approved 46 therapies, and strategic deals worth $2B have been made. Companies like Sangamo Therapeutics and 2seventy bio have also made significant strides in the industry.